(Q37828058)

23 August 2017

1 reference

title

Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease (English)

1 reference

23 August 2017

main subject

eosinophilic esophagitis

1 reference

D J Mulder

1

1 reference

23 August 2017

C J Justinich

series ordinal

2

1 reference

23 August 2017

language of work or name

1 reference

12 January 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

4

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

139-147

1 reference

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Pathology of eosinophilic esophagitis: what the clinician needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

21 January 2018

Eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Clinical and Endoscopic Features of Eosinophilic Esophagitis in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

The effect of infections on susceptibility to autoimmune and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eosinophil trafficking in allergy and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

IgE, mast cells, basophils, and eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Stimulation of human endothelium with IL-3 induces selective basophil accumulation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eosinophil cell: pray tell us what you do!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Human eosinophil granule major basic protein and its novel homolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eosinophils: biological properties and role in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

14 years of eosinophilic esophagitis: clinical features and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

The natural history and complications of eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Esophageal remodeling in pediatric eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Is the etiology of eosinophilic esophagitis in adults a response to allergy or reflux injury? Study of cellular proliferation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Development, migration, and survival of mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Mast cell tryptases and chymases in inflammation and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Pathways of murine mast cell development and trafficking: tracking the roots and routes of the mast cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Mast cells and eosinophils: the two key effector cells in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Histopathologic features of eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Antigen inhalation induces mast cells and eosinophils infiltration in the guinea pig esophageal epithelium involving histamine-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Mast cell-mediated long-lasting increases in excitability of vagal C fibers in guinea pig esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Involvement of mast cells in eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Esophageal subepithelial fibrosis in children with eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Infection with Gnathostoma spinigerum as a cause of eosinophilic oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eosinophilic esophagitis: a 10-year experience in 381 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Structure and function of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

B cell activation versus anergy; the antigen receptor as a molecular switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

How are T(H)2-type immune responses initiated and amplified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

IL-5 promotes eosinophil trafficking to the esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Regulatory T cells in the control of immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

The vast majority of CLA+ T cells are resident in normal skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

An etiological role for aeroallergens and eosinophils in experimental esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Common variants at 5q22 associate with pediatric eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Biologic therapy for inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Mepolizumab and eosinophil-mediated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Eosinophilic esophagitis: Escalating epidemiology?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Eosinophilic oesophagitis in infants and children in the region of southern Denmark: a prospective study of prevalence and clinical presentation.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Expression of P-selectin at low site density promotes selective attachment of eosinophils over neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Activated eosinophils in esophagitis in children: a transmission electron microscopic study

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Eosinophilic esophagitis in children with celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Cysteinyl leukotriene levels in esophageal mucosal biopsies of children with eosinophilic inflammation: are they all the same?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Mast cells modulate allergic pulmonary eosinophilia in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Direct evidence of mast cell participation in acute acid-induced esophageal inflammation in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Eosinophilic esophagitis and Barrett's esophagus with dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Anti–TNF-α (infliximab) therapy for severe adult eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.88

7 January 2021

Identifiers

DOI

10.1038/MI.2010.88

1 reference

23 August 2017

1 reference